Utility of a molecular pre-screening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials

Incorporation of multiple enrichment biomarkers into prospective clinical trials is an active area of investigation. This report examines the factors that correlate with successful clinical trial enrollment in a large molecular prescreening program in advanced colorectal cancer.

from Cancer via ola Kala on Inoreader http://ift.tt/1PTZqxn
via IFTTT